Patent ID: 11891625
Assignee: CHILDREN'S MEDICAL CENTER CORPORATION
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 18:
19. A method of treating a recipient with hematopoietic stem cells or progeny thereof, said method comprising:
a. providing a population of cells;
b. enriching said population of cells with hematopoietic stem cells according to the method of claim 1;
c. optionally differentiating said hematopoietic stem cells into common lymphoid progenitor cells, common myeloid progenitor cells, megakaryocyte-erythroid progenitor cells, granulocyte-megakaryocyte progenitor cells, granulocytes, promyelocytes, neutrophils, eosinophils, basophils, erythrocytes, reticulocytes, thrombocytes, megakaryoblasts, platelet-producing megakaryocytes, platelets, monocytes, macrophages, dendritic cells, microglia, osteoclasts, and lymphocytes, NK cells, B-cells and/or T-cells; and
d. introducing the population of cells enriched with hematopoietic stem cells or progeny thereof into said recipient.